NELFE

NELFE (NELF-E/RD) is the RNA-binding subunit of the four-subunit Negative Elongation Factor (NELF) complex, which cooperates with DSIF to repress RNA polymerase II transcriptional elongation at promoter-proximal pause sites until P-TEFb-mediated CTD phosphorylation releases the block (PMID:10199401). Its conserved RRM domain adopts a βαββαβ fold that binds single-stranded nascent RNA at a specific consensus motif (NBE, CUGAGGA(U)) enriched +20–30 nt downstream of transcription start sites in paused genes, thereby tethering NELF to the elongation complex (PMID:16898873, PMID:24453987). NELFE also directly engages the nuclear cap-binding complex (CBC) through its C-terminal peptide in a manner mutually exclusive with ARS2–PHAX, linking cap recognition to early transcriptional control, and is recruited to DNA double-strand breaks in a PARP1- and Pol II-dependent fashion to enforce transcriptional silencing and support DNA repair (PMID:29101316, PMID:28336775). Beyond its canonical elongation-control role, NELFE functions as an RNA-binding protein that destabilizes select mRNAs such as NDRG2 and amplifies MYC signaling, contributing to oncogenesis in hepatocellular and pancreatic cancers (PMID:28697339, PMID:31638184).

1. 1998 Low

   Before any functional data, NELFE was mapped to the HLA class III region arranged head-to-head with SKIV2L, establishing it as a ubiquitously expressed gene with a potential housekeeping role but no known mechanism.

   Evidence Genomic sequencing and expression analysis of the HLA class III locus

   PMID:9799600

   Open questions at the time

   • No functional or biochemical characterization performed
   • No evidence of protein-level activity
2. 1999 High

   The discovery that NELFE is a subunit of the NELF complex that cooperates with DSIF to repress Pol II elongation — reversible by P-TEFb — established the core mechanism of promoter-proximal pausing and defined NELFE as a putative RNA-binding component of this machinery.

   Evidence Biochemical purification from HeLa nuclear extract and reconstituted in vitro transcription elongation assay

   PMID:10199401

   Open questions at the time

   • RNA-binding activity of NELFE not directly demonstrated
   • No structural information on NELFE
   • In vivo relevance of pausing not tested
3. 2006 High

   Solving the NMR structure of the NELFE RRM and demonstrating its binding to single-stranded HIV-1 TAR RNA established that NELFE possesses a canonical RNA-recognition motif with low-micromolar affinity, confirming its RNA-binding function and defining the structural basis.

   Evidence NMR solution structure of recombinant NELF-E RRM; fluorescence equilibrium binding titrations

   PMID:16898873

   Open questions at the time

   • Endogenous RNA targets in the cell unknown
   • Role of RNA binding in pausing not directly tested
   • Whether NELFE recognizes a specific sequence motif remained unclear
4. 2014 High

   Identification of a specific consensus RNA motif (NBE) recognized by the NELFE RRM, and demonstration that NBE sequences are enriched at promoter-proximal pause sites genome-wide, provided the missing link between NELFE RNA binding and its role in establishing pausing at specific genes.

   Evidence In vitro SELEX, quantitative RNA-binding biochemistry, genome-wide bioinformatic analysis of NBE distribution near TSSs

   PMID:24453987

   Open questions at the time

   • Causal relationship between NBE presence and pausing not demonstrated by mutagenesis in vivo
   • Whether all paused genes require NBE-mediated NELF-E tethering is unclear
5. 2017 High

   Three independent studies expanded NELFE's functional repertoire: (1) crystal structure of the CBC–NELF-E peptide complex showed that NELFE directly binds CBC at a site mutually exclusive with ARS2–PHAX, linking cap recognition to pausing; (2) NELFE is recruited to DNA double-strand breaks in a PARP1- and Pol II-dependent manner to silence transcription and support repair; (3) NELFE copy-number amplification drives MYC signaling and hepatocellular carcinoma progression.

   Evidence Crystal structure and binding assays (CBC interaction); I-SceI/CRISPR DSB induction with live-cell recruitment and repair assays (DSB role); SCNA analysis of 1,225 HCC samples with functional KD/OE and transcriptomics (oncogenic role)

   PMID:28336775 PMID:28697339 PMID:29101316

   Open questions at the time

   • How CBC binding and RNA binding are coordinated on NELF-E during co-transcriptional pausing is not resolved
   • Mechanism of PARP1-dependent NELF-E recruitment to DSBs is not molecularly defined
   • Whether MYC amplification by NELFE depends on its elongation-control or RNA-destabilization activity is unknown
6. 2019 Medium

   Demonstration that NELFE destabilizes NDRG2 mRNA to activate Wnt/β-catenin signaling in pancreatic cancer established a direct mRNA-destabilizing activity distinct from its canonical elongation-repressive function.

   Evidence RNA immunoprecipitation, mRNA decay assays, and shRNA knockdown in pancreatic cancer cell lines

   PMID:31638184

   Open questions at the time

   • Mechanism of mRNA destabilization (e.g., recruited deadenylase/decapping) not identified
   • Whether NDRG2 mRNA is a direct RRM-mediated target or requires co-factors is unclear
   • Single-lab finding not independently replicated

• Key unresolved questions include how NELFE's RNA-binding (RRM–NBE) and cap-binding (CBC interaction) activities are structurally integrated on the paused elongation complex, the molecular mechanism by which NELFE destabilizes specific mRNAs independently of NELF-complex-mediated pausing, and whether its roles in DNA damage silencing and oncogenesis are mechanistically linked to its elongation-control function.
• No structure of the full NELF complex on a paused Pol II elongation complex with nascent RNA
• Mechanism of mRNA destabilization by NELFE not defined
• Relationship between elongation-control and oncogenic functions not dissected